Pfizer (PFE) Completes Tender Offer for Shares of Encysive Pharmaceuticals (ENCY)
Down)
Pfizer Inc (NYSE: PFE) announced that the subsequent offering period of the tender offer by its wholly-owned subsidiary, Explorer Acquisition Corp., to purchase all of the outstanding shares of common stock of Encysive Pharmaceuticals Inc. (NASDAQ: ENCY) at a purchase price of $2.35 per share, net to the seller in cash, without interest thereon and less any required withholding taxes, expired as of 5:00 p.m., New York City time, on April 14, 2008. According to the final report of the depositary for the tender offer, as of the expiration of the subsequent offering period, 69,076,466 shares, representing approximately 85.33% of the outstanding shares of Encysive common stock, were validly tendered and purchased pursuant to the offer. [JT]
Sign up at EasyStockAlerts.com & Make Money Today!
Sign up at EasyStockAlerts.com & Make Money Today!
You May Also Be Interested In
- Pfizer (PFE) Axitinib Gets Positive Opinion from CHMP EMA
- DigitalGlobe (DGI) Pops On Rumors of Higher Bid
- DISH Network (DISH) Sued by Networks for 'Commercial Skipping' Feature
Create E-mail Alert Related Categories
Corporate News, Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
